77.07 USD
↗ 0.76 (0.99%)LIVE (AS OF 03:02 PM EDT)
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
KNSANASDAQ • USD
Market: OPEN
Shares of Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA) are trading at $77.07. KNSA shows a split signal: underlying fundamentals suggest "Buy" while technical indicators indicate "Sell". Notable factors include a robust Altman Z-Score and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 5, 2026.
Open?$76.00
High?$77.23
Low?$73.92
Prev. Close?$76.31
Volume?220.2K
Avg. Volume?537.5K
VWAP?$75.85
Rel. Volume?0.41x
Bid / Ask
Bid?$76.69 × 100
Ask?$87.90 × 100
Spread?$11.21
Midpoint?$82.30
Valuation & Ratios
Market Cap?6.0B
Shares Out?48.3M
Float?39.2M
Float %?81.1%
P/E Ratio?73.82
P/B Ratio?9.10
EPS?$1.03
Dividend?0.40%
Ex-Dividend?N/A
News
Profile
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
Address
105 PICCADILLY, SECOND FLOOR
LONDON, W1J 7NJ
Phone: (781) 431-9100
LONDON, W1J 7NJ
Phone: (781) 431-9100
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?100
Momentum?73
Short Sent.?54
Piotroski F-Score?5/9Mixed
Altman Z-Score?16.09Safe
Confidence?68%Moderate
Short InterestHigh
Short % of Float?9.90%Elevated
Short Interest?3.9M
Days to Cover?7.2
Free Float39.2M
Avg Daily Volume537.9K
Settlement Date2026-09-15
Financial Health
Current Ratio?3.90Strong
Quick Ratio?3.49Strong
Cash Ratio?1.03Strong
Debt/Equity?0.13Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score39/100
P/E?73.8PRICEY▾
Peers100
S&P6
P/B?9.10HIGH▾
Peers100
S&P20
P/S?7.08HIGH▾
Peers100
S&P17
P/FCF?32.6FAIR▾
Peers100
S&P25
EV/EBITDA?57.5HIGH▾
Peers100
S&P3
EV/Sales?6.98HIGH▾
Peers100
S&P20
Returns & Efficiency
ROE?12.3%STRONG▾
Peers50
S&P44
ROA?9.0%STRONG▾
Peers50
S&P71
Cash Flow & Enterprise
FCF?$182.8M
Enterprise Value?$5.9B
Fundamentals ratios updated end of day